ELI LILLY GROUP LIMITED

Active Basingstoke

Manufacture of basic pharmaceutical products

0 employees website.com
Manufacture of basic pharmaceutical products
E

ELI LILLY GROUP LIMITED

Manufacture of basic pharmaceutical products

Founded 10 Sept 1979 Active Basingstoke, United Kingdom 0 employees website.com
Manufacture of basic pharmaceutical products
Accounts Submitted 19 Aug 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 17 Nov 2025 Next due 25 Nov 2026 6 months remaining
Net assets £108M £0 2024 year on year
Total assets £108M £0 2024 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

Eli Lilly And Company Limited, Lilly House Basingview Basingstoke Hampshire RG21 4FA United Kingdom

Full company profile for ELI LILLY GROUP LIMITED (01447831), an active company based in Basingstoke, United Kingdom. Incorporated 10 Sept 1979. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£108.49M

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Lilly Nederland Holding B.v.
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Eli Lilly And Company

United States Of America

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors As Firm,significant Influence Or Control As Firm

Group Structure

Group Structure

ELI LILLY GROUP LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Nov 2025Confirmation StatementConfirmation statement made on 11 Nov 2025 with no updates
3 Sept 2025OfficersChange to director Kristina Mignon Wright on 1 Sept 2025
19 Aug 2025AccountsAnnual accounts made up to 31 Dec 2024
14 Aug 2025OfficersTermination of Yuya Nonaka as director on 8 Aug 2025
14 Aug 2025OfficersAppointment of Kristina Mignon Wright as director on 8 Aug 2025
17 Nov 2025 Confirmation Statement

Confirmation statement made on 11 Nov 2025 with no updates

3 Sept 2025 Officers

Change to director Kristina Mignon Wright on 1 Sept 2025

19 Aug 2025 Accounts

Annual accounts made up to 31 Dec 2024

14 Aug 2025 Officers

Termination of Yuya Nonaka as director on 8 Aug 2025

14 Aug 2025 Officers

Appointment of Kristina Mignon Wright as director on 8 Aug 2025

Recent Activity

Latest Activity

Confirmation statement made on 11 Nov 2025 with no updates

5 months ago on 17 Nov 2025

Change to director Kristina Mignon Wright on 1 Sept 2025

8 months ago on 3 Sept 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 19 Aug 2025

Termination of Yuya Nonaka as director on 8 Aug 2025

8 months ago on 14 Aug 2025

Appointment of Kristina Mignon Wright as director on 8 Aug 2025

8 months ago on 14 Aug 2025